BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32486530)

  • 21. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1
    Agaimy A; Fuchs F; Moskalev EA; Sirbu H; Hartmann A; Haller F
    Virchows Arch; 2017 Nov; 471(5):599-609. PubMed ID: 28555282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status.
    Sousa V; Rodrigues C; Silva M; Alarcão AM; Carvalho L
    Rev Port Pneumol (2006); 2015; 21(3):113-25. PubMed ID: 25926253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
    Matsushima J; Yazawa T; Suzuki M; Takahashi Y; Ota S; Nakajima T; Yoshino I; Yokose T; Inoue T; Kawahara K; Nakatani Y
    Hum Pathol; 2017 Jun; 64():179-185. PubMed ID: 28438615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Pulmonary Mucoepidermoid Carcinoma: Histopathological and Moleculargenetic Studies of 26 Cases.
    Huo Z; Wu H; Li J; Li S; Wu S; Liu Y; Luo Y; Cao J; Zeng X; Liang Z
    PLoS One; 2015; 10(11):e0143169. PubMed ID: 26575266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study.
    McLeer-Florin A; Moro-Sibilot D; Melis A; Salameire D; Lefebvre C; Ceccaldi F; de Fraipont F; Brambilla E; Lantuejoul S
    J Thorac Oncol; 2012 Feb; 7(2):348-54. PubMed ID: 22071784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
    Zhu M; Li J; Zheng WH; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma.
    Xie M; Chen D; Li Y; Liu X; Kuang D; Li X
    Diagn Pathol; 2022 Feb; 17(1):30. PubMed ID: 35172862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization.
    Williams AS; Greer W; Bethune D; Craddock KJ; Flowerdew G; Xu Z
    Virchows Arch; 2016 Nov; 469(5):533-540. PubMed ID: 27562706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.
    Grosse A; Grosse C; Rechsteiner M; Soltermann A
    Diagn Pathol; 2019 Feb; 14(1):18. PubMed ID: 30744664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and prognosis of ciliated muconodular papillary tumor.
    Shao K; Wang Y; Xue Q; Mu J; Gao Y; Wang Y; Wang B; Zhou L; Gao S
    J Cardiothorac Surg; 2019 Jul; 14(1):143. PubMed ID: 31340823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
    Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methods.
    Kao HL; Yeh YC; Lin CH; Hsu WF; Hsieh WY; Ho HL; Chou TY
    Lung Cancer; 2016 Nov; 101():40-47. PubMed ID: 27794407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALK immunohistochemistry is highly sensitive and specific for the detection of ALK translocated lung adenocarcinomas: lessons from an audit of lung cancer molecular testing.
    Kheng YC; Walsh K; Williams L; Wallace WA; Harrison DJ; Oniscu A
    J R Coll Physicians Edinb; 2018 Mar; 48(1):20-24. PubMed ID: 29741520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.
    Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z
    Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Enteric Adenocarcinoma Lung with Mesenchymal Epithelial Transition Factor Amplification: A Case Report.
    Shukla S; Pandey RK; Husain N; Srivastava A
    Gulf J Oncolog; 2021 May; 1(36):76-78. PubMed ID: 35017140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ETV6-rearranged low-grade sinonasal non-intestinal-type adenocarcinoma: a clinicopathological analysis].
    Zhai CW; Yuan CC; Wang SY
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):55-59. PubMed ID: 33396988
    [No Abstract]   [Full Text] [Related]  

  • 38. EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma.
    Colombino M; Paliogiannis P; Cossu A; Santeufemia DA; ; Sini MC; Casula M; Palomba G; Manca A; Pisano M; Doneddu V; Palmieri G
    BMC Pulm Med; 2019 Nov; 19(1):209. PubMed ID: 31711449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy.
    Incharoen P; Reungwetwattana T; Saowapa S; Kamprerasart K; Pangpunyakulchai D; Arsa L; Jinawath A
    World J Surg Oncol; 2016 May; 14():139. PubMed ID: 27142166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of cytomorphology and molecular findings in EGFR+, KRAS+, and ALK+ lung carcinomas.
    Li Z; Dacic S; Pantanowitz L; Khalbuss WE; Nikiforova MN; Monaco SE
    Am J Clin Pathol; 2014 Mar; 141(3):420-8. PubMed ID: 24515771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.